Uncategorized
Anti-VEGF therapy may not have impact on cataract surgery outcomes in DME patients
MIAMI — Anti-VEGF therapy for the treatment of diabetic macular edema does not have a negative impact on patients who undergo cataract surgery, according to a speaker here.“There was no change in best corrected visual acuity observed from baseline to the last visit before surgery despite a decrease in central retinal thickness (CRT). As expected, there was no negative impact on visual acuity as a result of the cataract surgery. In fact, vision improved in both treatment groups after surgery,” Andrew A. Moshfeghi, MD, MBA, said at Angiogenesis, Exudation, and (Read more...)